MANE
Veradermics, Incorporated
Stock
$116.76−0.46 (−0.39%)Close Oct 2, 2026
Cash flow statement
| Line | 2025 | 2024 |
|---|---|---|
| Operating cash flow | −$72M | −$24M |
| Capital expenditures | $24K | $0 |
| Free cash flow | −$72M | −$24M |
| Stock-based compensation | $1.4M | $250K |
Veradermics, Incorporated
$116.76−0.46 (−0.39%)Close Oct 2, 2026
| Line | 2025 | 2024 |
|---|---|---|
| Operating cash flow | −$72M | −$24M |
| Capital expenditures | $24K | $0 |
| Free cash flow | −$72M | −$24M |
| Stock-based compensation | $1.4M | $250K |